| Literature DB >> 32731479 |
So Young Kim1, Yang-Sun Cho2, Ji-Soo Kim3, Ja-Won Koo4.
Abstract
Osteoporosis contributes to the occurrence of falling and vestibular problems, particularly in elderly patients. This study aimed to investigate the association between bone metabolism with vestibular problems and falling. A total of 4054 participants of the Korean National Health and Nutrition Examination Survey (KNHANES) from 2009 to 2010 aged ≥50 years old were surveyed on their history of falling, vestibular problems evaluated by the modified Romberg test, variables involving bone metabolism, and serum levels of vitamin D and alkaline phosphatase. They also underwent dual energy X-ray absorptiometry. The crude (simple) and adjusted odd ratios (ORs) of variables involving bone metabolism for vestibular problems in the modified Romberg test and falling were analyzed using a logistic regression model. A subgroup analysis was performed according to sex and the presence of menopause in females. Vestibular problems in the modified Romberg test group but not the falling group were associated with decreased serum vitamin D levels (p < 0.001; odds ratio (OR) = 0.951; 95% confidence interval (CI), 0.926-0.976). In subgroup analysis according to sex, the post-menopause group showed a higher rate of vestibular problems in the modified Romberg test compared to the pre-menopause group (4.5% vs. 0.7%, p = 0.019). In the post-menopause group, osteoporosis was positively associated with vestibular problems in the modified Romberg test (p = 0.001, OR = 10.971, 95% CI = 2.650-45.414). On the other hand, a history of hormone replacement therapy was negatively related with vestibular problems in this subgroup (p = 0.035; OR = 0.473; 95% CI = 0.239-0.948). A decrease in serum vitamin D levels may impact the vestibular system through neural signaling or by osteoporotic changes of the otic capsule, as well as otolith particles. Decreased estrogen levels in postmenopausal women may make them more prone to osteoporotic changes, which were associated with vestibular problems in the modified Romberg test. Because this is a cross-sectional study, the causal relationship of bone metabolism with vestibular function needs to be investigated.Entities:
Keywords: cohort studies; estrogens; osteoporosis; vestibular diseases; vitamin D
Year: 2020 PMID: 32731479 PMCID: PMC7466128 DOI: 10.3390/jcm9082415
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Schematic illustration of the method used for participant selection. (A) The participants with vestibular problems in the modified Romberg test were compared with control participants. (B) The participants with histories of falling were compared with control participants.
Prevalence of falling and vestibular problems in the modified Romberg test by sex, distribution of age and body mass index BMI in each group (n = 4054).
| Vestibular Problems in the Modified Romberg test (+) ( | Vestibular Problems in the Modified Romberg test (−) ( | OR | 95% CI | Falling (+) ( | Falling (−) ( | OR | 95% CI | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Age | 70.98 ± 8.19 | 62.55 ± 8.37 | <0.001 * | 1.097 | 1.067–1.127 | 65.32 ± 8.67 | 62.43 ± 8.42 | 0.012 * | 1.018 | 1.004–1.032 |
| Male | 3.4 a | 96.6 a | 0.1182 b | 1.248 | 0.901–1.729 | 11.0 | 89.0 | <0.001 *,b | 1.645 | 1.307–2.071 |
| Female | 4.3 a | 95.7 a | 19.0 | 81.0 | ||||||
| BMI (kg/m2) | 22.75 ± 3.13 | 24.07 ± 3.04 | <0.001 * | 0.863 | 0.809–0.920 | 23.76 ± 3.31 | 24.07 ± 3.00 | 0.004 | 0.952 | 0.921–0.985 |
Abbreviations: CI; confidence interval, BMI; body mass index, OR; odds ratio. a Percentage of the Korean population age 50 years or older. b Rao-Scott Chi-square test was used. c For the age-related trend test, logistic regression analysis was used. * p < 0.05.
Analysis of factors potentially associated with “vestibular problems in the modified Romberg test” in participants over 50 years old.
| % a | Vestibular Problems in the Modified Romberg Test (+) | Vestibular Problems in the Modified Romberg Test (−) | The Univariable Analysis | The Multivariable Analysis † | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||||||||
|
| ||||||||||||
|
| ||||||||||||
| No (%) | 75.5 | 3.7 | 96.3 | Referent | ||||||||
| Yes (%) | 24.5 | 4.5 | 95.5 | 0.238 | 1.237 | 0.869–1.760 | ||||||
| Hearing loss | ||||||||||||
| No (%) | 76.3 | 2.6 | 97.4 | Referent | Referent | |||||||
| Yes (%) | 23.7 | 8.1 | 91.9 | <0.001 * | 3.337 | 2.421–4.599 | 0.010 * | 1.63 | 1.123–2.365 | |||
| Falling | ||||||||||||
| No (%) | 84.6 | 2.9 | 97.1 | Referent | ||||||||
| Yes (%) | 15.4 | 9.1 | 90.9 | <0.001 * | 3.3 | 2.357–4.621 | ||||||
| General conditions for activity | ||||||||||||
| Limitation of activity | ||||||||||||
| No (%) | 78.6 | 2.7 | 97.3 | Referent | Referent | |||||||
| Yes (%) | 21.4 | 8.4 | 91.6 | <0.001 * | 3.355 | 2.431–4.631 | 0.003 * | 1.891 | 1.244–2.874 | |||
| Stress | ||||||||||||
| No (%) | 75.6 | 3.5 | 96.5 | Referent | ||||||||
| Yes (%) | 24.4 | 5.1 | 94.9 | 0.031 * | 1.46 | 1.036–2.057 | 0.451 | 1.169 | 0.779–1.753 | |||
| EQ-5D index (Mean) b,† | 0.91 ± 0.14 | 0.81 ± 0.21 | 0.91 ± 0.14 | <0.001 * | 0.046 | 0.022–0.096 | 0.11 | 0.404 | 0.133–1.226 | |||
| Visual disturbance | ||||||||||||
| No (%) | 98.6 | 3.8 | 96.2 | Referent | Referent | |||||||
| Yes (%) | 1.4 | 10.9 | 89.1 | 0.007 * | 3.099 | 1.307–7.346 | 0.503 | 0.699 | 0.245–1.994 | |||
| Underlying diseases | ||||||||||||
| Diagnosis of stroke | ||||||||||||
| No (%) | 97.1 | 3.9 | 96.1 | Referent | ||||||||
| Yes (%) | 2.9 | 5.1 | 94.9 | 0.5 | 1.334 | 0.577–3.080 | ||||||
| Diagnosis of osteoarthritis | ||||||||||||
| No (%) | 78.9 | 3.4 | 79.3 | Referent | Referent | |||||||
| Yes (%) | 21.1 | 5.7 | 94.3 | 0.002 * | 1.718 | 1.216–2.428 | 0.343 | 1.223 | 0.807–1.851 | |||
| Depressive mood | ||||||||||||
| No (%) | 83.3 | 3.7 | 96.3 | Referent | ||||||||
| Yes (%) | 16.7 | 4.7 | 95.3 | 0.23 | 1.275 | 0.857–1.897 | ||||||
| Diagnosis of depression | ||||||||||||
| No (%) | 95 | 3.9 | 96.1 | Referent | ||||||||
| Yes (%) | 5 | 4 | 96 | 0.962 | 1.018 | 0.493–2.103 | ||||||
| Diagnosis of Hypertension | ||||||||||||
| No (%) | 61.2 | 3 | 97 | Referent | Referent | |||||||
| Yes (%) | 38.8 | 5.3 | 94.7 | <0.001 * | 1.839 | 1.337–2.530 | 0.115 | 1.349 | 0.929–1.958 | |||
| Diagnosis of Diabetes | ||||||||||||
| No (%) | 86.1 | 3.6 | 96.4 | Referent | Referent | |||||||
| Yes (%) | 13.9 | 5.7 | 94.3 | 0.019 * | 1.613 | 1.083–2.403 | 0.18 | 1.35 | 0.870–2.095 | |||
| Diagnosis of Anemia | ||||||||||||
| No (%) | 90.7 | 3.6 | 96.4 | Referent | Referent | |||||||
| Yes (%) | 9.3 | 6.4 | 93.6 | 0.010 * | 1.803 | 1.152–2.822 | 0.361 | 0.785 | 0.467–1.319 | |||
| Osteoporosis | ||||||||||||
| Normal | 27.5 | 1.4 | 98.6 | Referent | ||||||||
| Osteopenia | 50.5 | 4 | 96 | <0.001 * | 2.953 | 1.659–5.256 | 0.15 | 1.555 | 0.853–2.835 | |||
| Osteoporosis | 22 | 6.8 | 93.2 | <0.001 * | 5.205 | 2.873–9.430 | 0.43 | 1.303 | 0.675–2.513 | |||
| DEXA T score (total femur) | −0.35 ± 1.03 | −0.97 ± 1.14 | −0.32 ± 1.01 | <0.001 * | 0.531 | 0.452–0.624 | ||||||
| DEXA T score (femur neck) | −1.24 ± 1.06 | −1.89 ± 1.15 | −1.21±1.05 | <0.001 * | 0.523 | 0.444–0.615 | ||||||
| DEXA T score (lumbar) | −1.22 ± 1.36 | −1.64 ± 1.49 | −1.20 ± 1.35 | <0.001 * | 0.776 | 0.683–0.882 | ||||||
| vitamin D (ng/mL) | 20.05 ± 7.22 | 18.57 ± 6.78 | 20.11 ± 7.23 | <0.001 * | 0.969 | 0.946–0.992 | <0.001 * | 0.951 | 0.926–0.976 | |||
| alkaline phosphatase (IU/L) | 247.18 ± 75.81 | 270.26 ± 94.72 | 246.24 ± 74.81 | <0.001 * | 1.003 | 1.002–1.005 | 0.108 | 1.002 | 1.000–1.004 | |||
| PTH (pg/mL) | 68.89 ± 29.99 | 73.59 ± 32.58 | 68.70 ± 29.86 | 0.047 * | 1.004 | 1.000–1.008 | ||||||
Some factors showing statistical significance in univariable analysis, such as DEXA T score at various anatomic sites, were not included in the logistic regression model due to the multicollinearity problems. Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index. a Sample weights applied. b Continuous variables are presented as mean ± standard deviation. † Clinically important variables with p values < 0.05 in the univariable analysis (age, sex, hearing loss, limitation of activity, EQ-5D index, visual disturbance, osteoarthritis, depression, hypertension, diabetes, anemia, osteoporosis, serum vitamin D level, alkaline phosphatase, and parathyroid hormone (PTH)) were included in the multivariable analysis. * p < 0.05
Analysis of factors potentially associated with “Falling” in participants over 50 years old.
| % a | Falling (+) | Falling (−) | The Univariable Analysis | The Multivariable Analysis † | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||||||||
|
| ||||||||||||
|
| ||||||||||||
| No (%) | 75.5 | 24.5 | 75.5 | Referent | Referent | |||||||
| Yes (%) | 24.5 | 12.5 | 87.5 | <0.001 * | 2.281 | 1.905–2.730 | <0.001 * | 1.907 | 1.562–2.328 | |||
| Hearing loss | ||||||||||||
| No (%) | 76.3 | 13.7 | 86.3 | Referent | Referent | |||||||
| Yes (%) | 23.7 | 21.0 | 79.0 | <0.001 * | 1.666 | 1.383–2.007 | 0.152 | 1.176 | 0.942–1.468 | |||
| General conditions for activity | ||||||||||||
| Limitation of activity | ||||||||||||
| No (%) | 78.6 | 12.6 | 81.3 | Referent | Referent | |||||||
| Yes (%) | 21.4 | 26.1 | 73.9 | <0.001 * | 2.457 | 2.043–2.954 | 0.002 * | 1.451 | 1.145–1.840 | |||
| Stress | ||||||||||||
| No (%) | 75.6 | 13.0 | 87.0 | Referent | Referent | |||||||
| Yes (%) | 24.4 | 22.5 | 77.5 | <0.001 * | 1.937 | 1.614–2.326 | 0.004 * | 1.391 | 1.110–1.743 | |||
| EQ-5D index (Mean) † | 0.90 ± 0.15 b | 0.84 ± 0.19 b | 0.92±0.13 b | <0.001 * | 0.051 | 0.030–0.086 | <0.001* | 0.286 | 0.141–0.578 | |||
| Visual disturbance | ||||||||||||
| No (%) | 98.6 | 15.2 | 84.8 | Referent | ||||||||
| Yes (%) | 1.4 | 36.4 | 63.6 | <0.001 * | 3.199 | 1.835–5.580 | 0.373 | 1.342 | 0.702–2.566 | |||
| Underlying diseases | ||||||||||||
| Diagnosis of Stroke | ||||||||||||
| No (%) | 97.1 | 15.3 | 84.7 | Referent | ||||||||
| Yes (%) | 2.9 | 21.2 | 78.8 | 0.082 | 1.492 | 0.951–2.339 | ||||||
| Diagnosis of Osteoarthritis | ||||||||||||
| No (%) | 78.9 | 13.9 | 86.1 | Referent | Referent | |||||||
| Yes (%) | 21.1 | 21.4 | 78.6 | <0.001 * | 1.688 | 1.393–2.045 | 0.707 | 1.046 | 0.827–1.324 | |||
| Depressive mood | ||||||||||||
| No (%) | 83.3 | 13.9 | 86.1 | Referent | Referent | |||||||
| Yes (%) | 16.7 | 23.0 | 77.0 | <0.001 * | 1.844 | 1.504–2.260 | 0.337 | 1.132 | 0.879–1.459 | |||
| Diagnosis of Hypertension | ||||||||||||
| No (%) | 61.2 | 13.6 | 86.4 | Referent | ||||||||
| Yes (%) | 38.8 | 18.3 | 81.7 | <0.001 * | 1.425 | 1.200–1.691 | 0.045 * | 1.230 | 1.005–1.504 | |||
| Diagnosis of Diabetes | ||||||||||||
| No (%) | 86.1 | 15.0 | 85.0 | Referent | Referent | |||||||
| Yes (%) | 13.9 | 18.3 | 81.7 | 0.042 * | 1.274 | 1.009–1.608 | 0.423 | 1.112 | 0.857–1.443 | |||
| Diagnosis of Anemia | ||||||||||||
| No (%) | 90.7 | 14.8 | 85.2 | Referent | Referent | |||||||
| Yes (%) | 9.3 | 21.5 | 78.5 | 0.001 * | 1.578 | 1.214–2.052 | 0.910 | 1.018 | 0.747–1.387 | |||
| Osteoporosis | ||||||||||||
| Normal | 27.5 | 10.4 | 89.6 | Referent | ||||||||
| Osteopenia | 50.5 | 15.5 | 84.5 | <0.001 * | 1.582 | 1.247–2.007 | 0.552 | 1.083 | 0.833–1.407 | |||
| Osteoporosis | 22.0 | 21.9 | 78.1 | <0.001 * | 2.422 | 1.864–3.147 | 0.574 | 1.099 | 0.790–1.529 | |||
| DEXA T score (total femur) | −0.35 ± 1.03 b | −0.59 ± 1.06 b | −0.30 ± 1.01 b | <0.001 * | 0.760 | 0.699–0.828 | ||||||
| DEXA T score (femur neck) | −1.24 ± 1.06 b | −1.56 ± 1.07 b | −1.18 ± 1.05 b | <0.001 * | 0.706 | 0.649–0.769 | ||||||
| DEXA T score (lumbar) | −1.22 ± 1.36 b | −1.52 ± 1.38 b | −1.16 ± 1.35 b | <0.001 * | 0.818 | 0.766–0.875 | ||||||
| vitamin D (ng/mL) | 20.05 ± 7.22 b | 19.79 ± 6.89 b | 20.10 ± 7.28 b | 0.329 | 0.994 | 0.982–1.006 | ||||||
| alkaline phosphatase (IU/L) | 247.18 ± 75.81 b | 251.01 ± 79.11 b | 246.48 ± 75.19 b | 0.169 | 1.001 | 1.000–1.002 | ||||||
| PTH (pg/mL) | 68.89 ± 29.99 b | 67.66 ± 29.27 b | 69.11 ± 30.11 b | 0.266 | 0.998 | 0.995–1.001 | ||||||
Some factors showing statistical significance in univariable analysis, such as DEXA T score at various anatomic sites, were not included in the logistic regression model due to the multicollinearity problems. Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index. a Sample weights applied. b Continuous variables are presented as mean ± standard deviation. † Clinically important variables with p values < 0.05 in the univariable analysis (age, sex, tinnitus, hearing loss, limitation of activity, stress, EQ-5D index, visual disturbance, stroke, osteoarthritis, depressive mood, hypertension, diabetes, anemia, and osteoporosis) were included in the multivariable analysis. * p < 0.05
Interactions among vitamin D, sex, and osteoporosis for the relation with the vestibular problems in the modified Romberg test.
| Model | R | R Square | F |
|
|---|---|---|---|---|
| Vitamin D | 0.052 | 0.003 | 9.929 | 0.002 * |
| Vitamin D * Sex | 0.057 | 0.003 | 5.909 | 0.003 * |
| Vitamin D * Sex * Osteoporosis | 0.108 | 0.012 | 14.374 | <0.001 * |
* p < 0.05.
Figure 2Serum vitamin D levels according to the vestibular problems in the modified Romberg test groups (* p < 0.05).
Figure 3Prevalence of osteoporosis in the vestibular problems in the modified Romberg test in each group (* p < 0.05).
Figure 4Schematic mechanisms underlying the relationship between bone metabolism and vestibular problem. Decreased estrogen levels in postmenopausal women disinhibit osteoclast activation and decrease activation of osteoblasts, resulting in bone resorption and subsequent osteoporotic changes (type 1 osteoporosis). The increase in parathyroid hormone due to secondary hypoparathyroidism induces specific cytokines that activate osteoclast precursor cells and induce osteoporotic changes (type 2 osteoporosis). Vitamin D has anabolic action in bone via activation of osteoblasts. The decrease in serum vitamin D levels can affect vestibular problems directly via dysfunction of the vitamin D receptor, which is expressed in vestibular organs (1), or by inducing osteoporotic changes related to degenerative changes in the otoliths and other vestibular organs (2).